Acumen Pharmaceuticals Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acumen pharmaceuticals company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acumen Pharmaceuticals Company Profile Today - Breaking & Trending Today

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Short Interest Down 12.0% in May

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Get Free Report) was the target of a large decrease in short interest in the month of May. As of May 15th, there was short interest totalling 816,000 shares, a decrease of 12.0% from the April 30th total of 926,900 shares. Based on an average trading volume of 297,900 shares, […] ....

United States , Dekabank Deutsche Girozentrale , Acumen Pharmaceuticals Trading Down , Institutional Investors Weigh In On Acumen Pharmaceuticals , Sg Americas Securities , Acumen Pharmaceuticals , Chicago Partners Investment Group , Acumen Pharmaceuticals Inc , News Ratings For Acumen Pharmaceuticals Daily , Citigroup Inc , Jump Financial , Acumen Pharmaceuticals Company Profile , Get Free Report , Partners Investment Group , Pharmaceuticals Trading Down , Acumen Pharmaceuticals Daily ,

Acumen Pharmaceuticals (NASDAQ:ABOS) Releases Earnings Results, Misses Expectations By $0.02 EPS

Acumen Pharmaceuticals (NASDAQ:ABOS – Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.25) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.23) by ($0.02), Zacks reports. During the same period last year, the firm posted ($0.28) earnings per share. Acumen Pharmaceuticals Stock Performance Shares of ABOS stock […] ....

News Ratings For Acumen Pharmaceuticals Daily , Earnings History For Acumen Pharmaceuticals , Acumen Pharmaceuticals Stock Performance , Acumen Pharmaceuticals Company Profile , Acumen Pharmaceuticals Inc , Acumen Pharmaceuticals , Get Free Report , Acumen Pharmaceuticals Daily ,

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Short Interest Update

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Get Free Report) was the recipient of a large decrease in short interest during the month of April. As of April 15th, there was short interest totalling 1,050,000 shares, a decrease of 15.3% from the March 31st total of 1,240,000 shares. Based on an average daily volume of 341,300 shares, […] ....

United States , Acumen Pharmaceuticals , Jump Financial , Acumen Pharmaceuticals Company Profile , Acumen Pharmaceuticals Trading , News Ratings For Acumen Pharmaceuticals Daily , Acumen Pharmaceuticals Inc , Franklin Resources Inc , Parkman Healthcare Partners , Chicago Partners Investment Group , Institutional Investors Weigh In On Acumen Pharmaceuticals , Get Free Report , Partners Investment Group , Healthcare Partners , Hudson Bay Capital Management , Bay Capital Management , Acumen Pharmaceuticals Daily , Nasdaq Abos ,

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Sees Large Increase in Short Interest

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Get Free Report) was the target of a significant growth in short interest in January. As of January 15th, there was short interest totalling 699,400 shares, a growth of 53.6% from the December 31st total of 455,200 shares. Approximately 1.8% of the company’s stock are short sold. Based on an […] ....

United States , Daniel Joseph Oconnell , Derekm Meisner , American International Group Inc , News Ratings For Acumen Pharmaceuticals Daily , Acumen Pharmaceuticals Inc , Acumen Pharmaceuticals , Acumen Pharmaceuticals Company Profile , Securities Exchange Commission , Chicago Partners Investment Group , Deutsche Bank Aktiengesellschaft , Acumen Pharmaceuticals Stock Down , Get Free Report , Pharmaceuticals Stock Down , Exchange Commission , Joseph Oconnell , State Teachers Retirement System , International Group , Street Group , Acumen Pharmaceuticals Daily , Nasdaq Abos ,

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Insider Derek M. Meisner Sells 8,933 Shares

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Insider Derek M. Meisner Sells 8,933 Shares
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Derekm Meisner , Securities Exchange Commission , Acumen Pharmaceuticals Company Profile , Acumen Pharmaceuticals , Acumen Pharmaceuticals Trading Down , Deutsche Bank Aktiengesellschaft , News Ratings For Acumen Pharmaceuticals Daily , Acumen Pharmaceuticals Inc , American International Group Inc , Institutional Trading Of Acumen Pharmaceuticals , Chicago Partners Investment Group , Get Free Report , Exchange Commission , Pharmaceuticals Trading Down , State Teachers Retirement System , International Group , Street Group , Acumen Pharmaceuticals Daily ,